MM-093 clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How each study uses MM-093 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- MM-093
- 4
Studies by the year they started
4 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses MM-093 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Phase 2 Study of MM-093 to Treat Patients With UveitisCompletedPhase 2Merrimack PharmaceuticalsNCT00444743Written as MM-093How we know
- Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX)CompletedPhase 2Merrimack PharmaceuticalsNCT00105976Written as MM-093How we know
- A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid ArthritisCompletedPhase 2Merrimack PharmaceuticalsNCT00458146Written as MM-093How we know
- Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque PsoriasisCompletedPhase 2Merrimack PharmaceuticalsNCT00147329Written as MM-093How we know